Expression of MYC and BCL2 proteins is identified by immunohistochemistry (IHC) in some patients with DLBCL even when the chromosomal rearrangements of DH/TH lymphoma are not present. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.